Increasing unusual option volume: DINO CTMX ABUS RYAM EWY AMPY PBF ODD BNO Mar 5, 2026 04:45AM
Increasing unusual option volume: ABUS GLNG COUR EWY BGS BOX TECK WTI EXAS FSLY ROST FLNG LASR Mar 4, 2026 09:52AM
Chardan Reiterates Buy Rating on Arbutus Biopharma (ABUS) Following Moderna Settlement Mar 4, 2026 09:21AM
After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more Mar 3, 2026 04:33PM
Roivant's Genevant and Arbutus reach $2.25 billion settlement with Moderna Mar 3, 2026 04:16PM


Feb 6, 2026 04:04PM Arbutus Biopharma wins patent ruling against Moderna
Jan 27, 2026 10:38AM Increasing unusual option volume: ABUS ECH AMTX ZSL RVMD XNET GFS CX UMC
Jan 16, 2026 07:45AM Arbutus patent revoked by European Patent Office board
Nov 13, 2025 04:12PM Arbutus Biopharma (ABUS) Misses Q3 EPS by 1c
Aug 6, 2025 07:55AM Arbutus Biopharma (ABUS) Tops Q2 EPS by 5c
Jun 25, 2025 07:32AM Arbutus Biopharma (ABUS) Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
May 14, 2025 04:28PM Arbutus Biopharma (ABUS) Misses Q1 EPS by 3c
Mar 31, 2025 05:23AM Citizens JMP Reiterates Market Outperform Rating on Arbutus Biopharma (ABUS)
Mar 3, 2025 09:15AM Genevant Sciences (ROIV) and Arbutus Biopharma (ABUS) Initiate International Patent Infringement Enforcement Actions Against Moderna
Feb 25, 2025 07:04AM Arbutus Biopharma (ABUS) Appoints Lindsay Androski as CEO, Announces Board Changes
Jan 13, 2025 07:30AM Arbutus Biopharma (ABUS) Provides 2025 Corporate and Financial Update
Nov 15, 2024 11:01AM Arbutus Biopharma (ABUS) and Barinthus Bio (BRNS) Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
Aug 1, 2024 07:34AM Arbutus Biopharma (ABUS) Misses Q2 EPS by 1c
Aug 1, 2024 07:25AM Arbutus Biopharma (ABUS) Halted, News Pending
Jun 20, 2024 05:34AM Increasing unusual option volume: ABUS TSEM BMBL IAU CMTL GTHX